CXCR antagonistic peptides and uses thereof
US9981003B2 · kind B2 · utility
1Cited by
0References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 25, 2014 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Nov 25, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a novel class of medicament based on CXCR antagonistic peptides. Among other things, the present invention provides peptides, compositions and methods for treating diseases, disorders and conditions in which a CXCR mediated pathway is implicated. Compositions and methods for effective treatment of inflammation, stroke, traumatic brain injury, pancreatic cancer, and others are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.